2. Srikanth N. Polycythemia Vera. Medscape.2022. https://emedicine.medscape.com/article/205114-overview
3. Aljabry MS. Primary familial and congenital polycythemia; The forgotten entity. JAppl Hematol 2018;9:39-44. DOI: 10.4103/joah.joah_30_18. https://www.jahjournal.org/article.asp?issn=1658-5127;year=2018;volume=9;issue=2;spage=39;epage=44;aulast=Aljabry
6. Tefferi A, Barbui T. Polycythemia vera and essential thrombocythemia: 2017 update on diagnosis, risk-stratification, and management. American Journal of Hematology, 2016. 92(1): 94–108. doi:10.1002/ajh.24607
8. Pillai AA, Babiker HM. Polycythemia. In: StatPearls Treasure Island (FL): StatPearls Publishing; 2022. https://www.ncbi.nlm.nih.gov/books/NBK526081
9. McMullin MF, Harrison CN, Ali S, et al. A guideline for the diagnosis and management of polycythaemia vera. A British Society for Haematology Guideline. British Journal of Haematology, 2018. doi:10.1111/bjh.15648
11. Lee G, Arcasoy MO. The clinical and laboratory evaluation of the patient with erythrocytosis. Eur J Intern Med. 2015 Jun;26(5):297-302. doi: 10.1016/j.ejim.2015.03.007.
12. Tefferi A. Prognosis and treatment of polycythemia vera. 2022. UpToDAte https://www.uptodate. com/contents/prognosis-and-treatment-of-polycythemia-vera
15. Passamonti F, Rumi E, Pungolino E, Malabarba L, Bertazzoni P, Valentini M, Orlandi E, Arcaini L, Brusamolino E, Pascutto C, Cazzola M, Morra E, Lazzarino M. Life expectancy and prognostic factors for survival in patients with polycythemia vera and essential thrombocythemia. Am J Med. 2004 Nov 15;117(10):755-61. doi: 10.1016/j.amjmed.2004.06.032. PMID: 15541325.